Facebook Linkedin Soundcloud X Vimeo Xing
  • About
    • Changing Physician Behavior
    • Publications
      • Onco’Zine
        • The Onco’Zine Brief
        • The Onco’Zine Dossier
          • Episodes
      • Changing Strategies in the War on Cancer
        • Changing Strategies in the War on Cancer – Episode 1
        • Changing Strategies in the War on Cancer – Episode 2
        • Changing Strategies in the War on Cancer – Episode 3
      • Journal of CAR T-Cell Therapy
        • About CAR T-cells
        • Frequently Asked Questions
        • Types of Articles
        • Submit a Manuscript
    • Advisory Board
      • Join Our Editorial Advisory Board
    • Call for Papers
      • Submission Guidelines
      • Instructions for Authors: Introduction
      • Step 1: Before You Begin the Submission Process
      • Step 2: Prepare to Submit Your Manuscript
    • Download Our Media Kit
    • Sponsor Opportunities
    • Partners
    • Feedback
    • Subscribe
    • Contact
    • Cookie Policy
  • Articles
    • Editorial
    • News
      • Business & Economics
      • Conference Coverage
      • Must Read Articles
      • Clinical Trials Update
    • Peer Review
    • The Review
  • Resources for Clinicians
    • ADC Package Inserts
    • Gemtuzumab ozogamicin (Mylotarg®) Part 1
    • Clinical Trials
  • ADC Drug Map
  • ADC Directory
    • Join Today
    • ADC University
      • Resources
    • ADC Review | The Bookstore
      • ADC Review | The Bookstore – Lyophilization of Pharmaceuticals and Biologicals
      • ADC Review | The Bookstore – Bioconjugation: Methods and Protocols
      • ADC Review | The Bookstore – Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes
      • ADC Review | The Bookstore – Analytical Characterization of Biotherapeutics
      • ADC Review | The Bookstore – Antibody Drug Discovery | Molecular Medicine and Medicinal Chemistry
      • ADC Review | The Bookstore – Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
      • ADC Review | The Bookstore – Antibody-Drug Conjugates Methods in Molecular Biology
      • ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
      • ADC Review | The Bookstore – Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer 1st Edition
      • ADC Review | The Bookstore – Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications
      • ADC Review | The Bookstore – Antibody-Drug Conjugates: Methods and Protocols (Methods in Molecular Biology) 1st ed. 2020 Edition
      • ADC Review | The Bookstore – Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer
      • ADC Review | The Bookstore – Cytotoxic Payloads for Antibody–Drug Conjugates
      • ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
    • Video Library
Search
Facebook Linkedin Soundcloud X Vimeo Xing
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
ADC Review ADC Review
ADC Review ADC Review
  • About
    • Changing Physician Behavior
    • Publications
      • Onco’Zine
        • The Onco’Zine Brief
        • The Onco’Zine Dossier
          • Episodes
      • Changing Strategies in the War on Cancer
        • Changing Strategies in the War on Cancer – Episode 1
        • Changing Strategies in the War on Cancer – Episode 2
        • Changing Strategies in the War on Cancer – Episode 3
      • Journal of CAR T-Cell Therapy
        • About CAR T-cells
        • Frequently Asked Questions
        • Types of Articles
        • Submit a Manuscript
    • Advisory Board
      • Join Our Editorial Advisory Board
    • Call for Papers
      • Submission Guidelines
      • Instructions for Authors: Introduction
      • Step 1: Before You Begin the Submission Process
      • Step 2: Prepare to Submit Your Manuscript
    • Download Our Media Kit
    • Sponsor Opportunities
    • Partners
    • Feedback
    • Subscribe
    • Contact
    • Cookie Policy
  • Articles
    • Editorial
    • News
      • Business & Economics
      • Conference Coverage
      • Must Read Articles
      • Clinical Trials Update
    • Peer Review
    • The Review
  • Resources for Clinicians
    • ADC Package Inserts
    • Gemtuzumab ozogamicin (Mylotarg®) Part 1
    • Clinical Trials
  • ADC Drug Map
  • ADC Directory
    • Join Today
    • ADC University
      • Resources
    • ADC Review | The Bookstore
      • ADC Review | The Bookstore – Lyophilization of Pharmaceuticals and Biologicals
      • ADC Review | The Bookstore – Bioconjugation: Methods and Protocols
      • ADC Review | The Bookstore – Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes
      • ADC Review | The Bookstore – Analytical Characterization of Biotherapeutics
      • ADC Review | The Bookstore – Antibody Drug Discovery | Molecular Medicine and Medicinal Chemistry
      • ADC Review | The Bookstore – Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
      • ADC Review | The Bookstore – Antibody-Drug Conjugates Methods in Molecular Biology
      • ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
      • ADC Review | The Bookstore – Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer 1st Edition
      • ADC Review | The Bookstore – Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications
      • ADC Review | The Bookstore – Antibody-Drug Conjugates: Methods and Protocols (Methods in Molecular Biology) 1st ed. 2020 Edition
      • ADC Review | The Bookstore – Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer
      • ADC Review | The Bookstore – Cytotoxic Payloads for Antibody–Drug Conjugates
      • ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
    • Video Library
Home Authors Posts by Danielle Garcia

Danielle Garcia

Danielle Garcia
89 POSTS 0 COMMENTS
A proactive, determined and intra-entrepreneur, Garcia has more than 10 years of experience in the areas of medical and pharmaceutical communication, press relations, organizational communication and digital marketing. Garcia is also an experienced people manager and, with a focus on oncology and hematology, she provides targeted training and presentations (webinars) in all aspects of (bio-) pharmaceutical manufacturing.
Daiichi Sankyo

Daiichi Sankyo Submits Supplemental New Drug Application for Trastuzumab Deruxtecan in...

Danielle Garcia
Daiichi Sankyo, Basking Ridge, NJ. Courtesy: Daiichi Sankyo.

Daiichi Sankyo Starts First-in-Human Phase I/II Study Evaluating DS-7300

Danielle Garcia

Innate Pharma Confirms Securing Investment to Develop Novel ADC

Danielle Garcia
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

Phase I/IIa Trial Evaluating BT1718 Shows Encouraging Progress in Dose Escalation...

Danielle Garcia
antibody

Webinar: When to Apply Design of Experiments (DoE) to ADC Development

Danielle Garcia

Anti-VEGF antibody biopolymer conjugate KSI-301 in Treatment of Retinal Vascular Diseases...

Danielle Garcia

Kent Payne, Ph.D. and Brandon Price, Ph.D. Join the Board of...

Danielle Garcia
Boston

Conagen Acquires Therapeutic Proteins Production Platform

Danielle Garcia

Mersana Therapeutics Initiates Expansion Study of XMT-1536 in Platinum-Resistant Ovarian Cancer...

Danielle Garcia

NanoValent Receives Patent for Targeted Polymerized Nanoparticles in Cancer Treatment

Danielle Garcia
1...789Page 8 of 9
  • ProjectPharmaceuticals
  • Piramal
  • Lonza May 2026
  • Axplora
  • Your Support
Advertise with us
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Rinatabart Sesutecan Produces Durable Responses in Platinum-Resistant Ovarian Cancer in RAINFOL-01 Part C

Danielle Garcia

Axplora Advances European Exatecan Supply Route for Topoisomerase I Inhibitor ADCs

Danielle Garcia

Daiichi Sankyo and Merck & Co/MSD Withdraw BLA for Ifinatamab Deruxtecan in Treated ES-SCLC

Peter Hofland

Peer Review

How ADCs changed the oncology clinical landscape

Dowdy Jackson, PhD

Beyond Random: Why Site-Specific Conjugation Is Redefining the ADC Therapeutic Window

Nicholas Lim , PhD

After CAR T-Cell Relapse in Mantle Cell Lymphoma, a CD79b-Targeted ADC Produces Durable Remission

Danielle Garcia
  • About
  • Contact
  • Copyright
  • Feedback
  • Privacy
  • Terms
© 2013-2024 Sunvalley Communication, LLC. All Rights Reserved.

X